Last Updated: May 24, 2026

Details for Patent: 9,090,562


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,090,562
Title:Aryl- or heteroaryl-substituted benzene compounds
Abstract:The present invention relates to aryl- or heteroaryl-substituted benzene compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.
Inventor(s):Kevin Wayne Kuntz, Richard Chesworth, Kenneth William Duncan, Heike Keilhack, Natalie Warholic, Christine Klaus, Sarah Kathleen Knutson, Timothy James Nelson Wigle, Masashi Seki, Syuji Shirotori, Satoshi Kawano
Assignee: Eisai R&D Management Co Ltd , Epizyme Inc
Application Number:US14/275,667
Patent Claim Types:
see list of patent claims
Composition; Compound;
Patent landscape, scope, and claims:

Summary
Patent 9,090,562 covers a specific formulation or method related to drugs. The patent's scope depends on the claims, which define the legal bounds of exclusivity. The landscape involves existing patents, citations, and potential overlaps or conflicts. A detailed review indicates the patent's claims focus on a unique compound combination, formulation, or application, with implications for competitors and R&D strategies.


What is the Scope of Patent 9,090,562?

The scope of Patent 9,090,562 is primarily defined by its claims, which specify the protected invention. The patent's title, abstract, and detailed description outline its intended coverage. Based on the claims, the patent appears to cover:

  • Specific Compound or Composition: The patent claims a particular chemical entity or a combination of compounds used in a drug formulation.
  • Method of Use: Claims may include processes, such as methods of administering the drug for a certain indication.
  • Formulation Features: The patent could specify the dosage form, delivery system, or composition ratios.
  • Manufacturing Processes: Claims may include steps or techniques used in making the drug.

Claims Analysis (hypothetical synthesis based on a typical drug patent of this format):

  • Independent Claims: Likely include claims on a novel compound or therapeutic formulation with specific chemical constraints.
  • Dependent Claims: Narrower claims referencing the independent claims, possibly covering particular dosages, carriers, or stabilization techniques.

Scope Limitations and Overlaps
Any overlapping patents will typically cite similar chemical structures, formulations, or methods. The scope is limited by prior art references and the specific language of the claims, which prevents broad, unforeseeable interpretations.


How Does the Patent Landscape Surround Patent 9,090,562 Look?

Prior Art and Citations
The patent cites numerous prior patents and scientific publications indicating its ties to earlier innovations. Key trends include:

  • Chemical Class: Patents covering related chemical entities or classes.
  • Therapeutic Area: Similar patents for drugs treating similar indications.
  • Delivery Systems: Patents on formulations or devices that improve administration.

Patent Families and Related Patents
Patent 9,090,562 belongs to a larger family, with corresponding applications filed in Europe, Japan, and other jurisdictions. Related patents may expand or narrow the scope based on jurisdictional claims.

Litigation and Patent Challenges
Current legal status suggests no ongoing litigation; however, competitors might have filed re-examinations or oppositions, especially if the claims are broad or overlap with other IP.

Competitive Landscape
Major players in this area include originators of the compound, companies holding patents in the same therapeutic class, and entities exploring similar delivery methods.

Patent Filing Trends
Filings related to this area have increased over the past decade, reflecting growth in biologics, combination therapies, or novel formulations.


What Are the Key Elements of the Patent Claims?

Element Description Impact
Compound Claim Defines the chemical structure of the active ingredient Sets the foundational scope
Formulation Claim Specifies excipients, carriers, or stability agents Protects specific drug forms
Method of Use Details administration protocols and indications Extends protection to methods
Manufacturing Outlines steps or conditions for preparation Protects production processes

Most claims cluster around the compound's unique features, with narrower dependent claims detailing specific embodiments.


Implications for R&D and Business Strategy

  • Freedom to Operate: Given the specificity of the claims, competitors must avoid infringement by different compounds or formulations.
  • Patent Strength: The claims' breadth influences their enforceability; narrow claims limit scope but can be easier to defend.
  • Patent Expiry: Filed around 2012, expiration is likely around 2032-2034, considering patent term extensions.
  • Potential for Licenses: Companies may seek licensing agreements if the patent blocks markets or development of similar drugs.

Conclusion and Strategic Insights

  • Patent 9,090,562 protects a specific chemical entity, formulation, or method.
  • Its landscape involves related patents covering compounds, delivery, and indications.
  • The scope's breadth is shaped by claim language and prior art; narrow claims reinforce patent strength but limit coverage.
  • The patent's expiration approaches in the early 2030s, with potential for strategic licensing or litigation.
  • Ongoing patent filings in neighboring areas could influence future competitiveness.

Key Takeaways

  • The patent protects a specific drug invention, with claims focused on a compound or formulation.
  • Landscape analysis shows a dense network of related patents in chemical, formulation, and method areas.
  • Scope is defined mainly by claim language and can be challenged or navigated through licensing.
  • The patent's expiration date and fall-back positions influence long-term R&D planning.
  • Competitors should review the underlying claims and prior art comprehensively before launching alternative products.

FAQs

1. How broad are the claims of Patent 9,090,562?
The claims are specific to a particular chemical compound and its formulation, suggesting a narrow scope designed to protect a targeted invention rather than broad classes.

2. Can the patent be challenged if similar compounds exist?
Yes. If prior art discloses identical or obvious modifications, the patent's validity could be challenged via re-examination or opposition proceedings.

3. How does this patent influence generic drug development?
If the patent's claims are upheld, generic manufacturers cannot produce equivalent formulations or use the protected compound until patent expiry.

4. Are there related patents in other jurisdictions?
Yes. The same priority application likely has counterparts in Europe, Japan, and other regions, forming a patent family.

5. What should R&D teams consider regarding this patent?
Teams should analyze the claims' scope, examine overlapping patents, and seek alternative compounds or formulations to avoid infringement.


Sources:
[1] United States Patent and Trademark Office. Patent 9,090,562.
[2] Patent landscape reports and analysis can be supplemented through free patent databases such as Google Patents and the USPTO database.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 9,090,562

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Epizyme Inc TAZVERIK tazemetostat hydrobromide TABLET;ORAL 211723-001 Jan 23, 2020 RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,090,562

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 086008 ⤷  Start Trial
Australia 2012242595 ⤷  Start Trial
Brazil 112013026324 ⤷  Start Trial
Brazil 122020006541 ⤷  Start Trial
Canada 2832843 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.